| 1999 - 724 lapas
...wherever appropriate; (viii) The name and place of business of manufacturer, packer, or distributor; (ix) A lot or control number, identified as such, from...the complete manufacturing history of the product; (x) For class I exempt ASR's, the statement: "Analyte Specific Reagent. Analytical and performance... | |
| 1996 - 672 lapas
...amount of material provided. (8) Name and place of business of manufacturer, packer, or distributor. (9) A lot or control number, identified as such, from...the complete manufacturing history of the product. (i) If it is a multiple unit product, the lot or control number shall permit tracing the identity of... | |
| 1990 - 198 lapas
...the complete manufacturing history of the package of the drug; Provided, however, That in the case of containers too small or otherwise unable to accommodate...with sufficient space to bear all such information, but which are packaged within an outer container from which they are removed for dispensing or use,... | |
| 2003 - 210 lapas
...adequate container)": Provided, however, That in the case of containers too 21 CFR Ch. I (4-1-03 Edition) small or otherwise unable to accommodate a label with sufficient space to bear all such information, but which are packaged within an outer container from which they are removed for dispensing or use,... | |
| 1999 - 596 lapas
...granted by the US Food and Drug Administration or by the US Department of Agriculture. In the case of containers too small or otherwise unable to accommodate a label with sufficient space to bear the caution statements required by paragraph (a) or (b) of this section, the statements may be included... | |
| 1972 - 488 lapas
...manufacturing history of the package of the drug; Provided, however. That in the case of containers too sm^ll or otherwise unable to accommodate a label with sufficient space to bear all such information, but which are packaged within an outer container from which they are removed for dispensing or use,... | |
| 2002 - 228 lapas
...reasonably related to the size and prominence of the front-panel display. (i) A drug packaged in a container too small or otherwise unable to accommodate a label with sufficient space to bear the information required for compliance with section 502(e)(l) (A)(ii) and (B) of the act shall be... | |
| 1998 - 196 lapas
...reasonably related to the size and prominence of the front-panel display. (i) A drug packaged in a container too small or otherwise unable to accommodate a label with sufficient space to bear the information required for compliance with section 502(e)(1) (A)(ii) and (B) of the act shall be... | |
| 1998 - 1120 lapas
...the other than oral use; (7) The net quantity of contents; (8) An identifying lot or control number from which it is possible to determine the complete manufacturing history of the package of the drug; (9) The name and address of the manufacturer, packer, or distributor; (10) The... | |
| 1961 - 674 lapas
...the quantity or proportion of all inactive ingredients; and (vi) An identifying lot or control number from which it is possible to determine the complete manufacturing history of the package of the drug; Provided, however, That in the case of containers too small or otherwise unable... | |
| |